Global Generics & Biosimilars Awards 2024
Milan, Italy
Generic Medicines 35th Birthday Celebration
September 24 marks the 35th anniversary of President Reagan signing into law the Hatch-Waxman Amendments, which provided the framework for the modern generic drug industry and created the proper balance between innovation and access in the pharmaceutical ecosystem. With the intense focus on drug prices among patients, the president, Capitol Hill and the media it […]
NAFTA 2.0 Congressional Briefing: The May 10 Amendments
Noon – 1:00 PM 2456 Rayburn House Office Building, Capitol Hill Congressional Briefing: The May 10 Amendments: How the 2007 Bipartisan Deal Informs Today’s NAFTA 2.0 Debate FLASHBACK. On May 10, 2007, House Democrats worked with a Republican president and successfully reached a bipartisan agreement on trade. The trade deal resolved concerns around patient access […]
Patient Access to Affordable Medicines: How a Renegotiated NAFTA Could Keep Drug Prices High
Friday, September 14, 2018 Noon–1:00 p.m. 1310 Longworth House Office Building Committee on House Administration Hearing Room On August 31, President Trump notified Congress of his intent to sign a trade agreement with Mexico. This agreement could have a significant impact on the United States’ economy, including prescription drug pricing and the emerging biosimilars market. […]
Biosimilars Briefing: The Challenge & Promise for Patient Access
2045 Rayburn House Office Building
Washington
